Narrow Results

Strategic Commercial Partnership for Australian Biotech Innovation.

AGT Partners IPD in Anti-Obesity Therapies Development.

Genesis Biomedical Acquires ENSI~MED.

Sulfa Drug Output Increases Despite Declining Demand.

China's Pharmaceutical Retail Market in First Half 2003.

Shanghai Company Collaborates with Inner Mongolia Pharma Group.

Venkateshwara Group Creates New Vaccine Manufacturing Division.

Pfizer India Prioritized as Prime R&D Hub.

Pharmac Caught in Losec Dispute.

Cardinal Health Establishes Singapore Operation.

The Lab Rat Cloned At Last!.

Researchers Closer to Developing Ebola Vaccine.

Spit Here Please — Saliva as a Diagnostic Tool.

Cholesterol-lowering Drug May Alleviate Alzheimer’s.

In this issue, APBN looks at the technology that have improved our understanding of the human body and paved the way for future treatments and therapies.

First off, we learn about pneumococcal vaccination and how it offers protection against bacterial pneumonia with Dr Chew Huck Chin, respiratory physician and intensivist at Mount Elizabeth Novena Hospital. Then, we hear from Yutaka Shimokawa, Founder and CEO of KINS, about how gut microbes can improve women's hormonal health.

In Spotlights, we bring you the highlights from the recent Asia Summit on Global Health as well as an interview with Dr Tan Hong Chang, Senior Consultant at the Singapore General Hospital, and Associate Professor Liu Yu-Chi, Clinician Scientist at the Singapore National Eye Centre, on how a cholesterol drug was repurposed as a new treatment for diabetic corneal neuropathy.

In Columns, Dr Jane Leong, Vice President, Medical Affairs Asia Pacific for Moderna, shares how recent developments in mRNA technology could change the way we approach cancer other diseases.

In this issue, we have two highlights that will look at how far imaging technologies have come since the X-ray. First, Keefe Chee from BD Life Sciences, Singapore, discusses how real-time imaging spectral flow cytometry (RTI-SFC) allows scientists to identify previously unclassifiable cells in real time, bridging a long-standing gap in biomedical research.

And then we have Torrey Smith, CEO of Endiatx, to share with us about PillBot™, the world's first motorised pill camera that will allow a doctor to view the entire stomach and assess for any lesions, making stomach cancer diagnosis more accessible and palatable.

Finally, some research highlights we have this issue include a novel diagnostic tool that will improve the clinical diagnosis of neurodegenerative disorders, a textile that can convert body movement into electricity, and a uterine tissue-specific hydrogel that could aid in infertility.